Disc Medicine
IRON
44 hedge funds and large institutions have $34.3M invested in Disc Medicine in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 12 closing their positions.
36% more call options, than puts
Call options by funds: $235K | Put options by funds: $173K
2% more capital invested
Capital invested by funds: $33.7M → $34.3M (+$610K)
0.06% more ownership
Funds ownership: 2% → 2.06% (+0.06%)
12% less funds holding
Funds holding: 50 → 44 (-6)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
43% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 14
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.46M |
| 2 |
5VM
5AM Venture Management
San Francisco,
California
|
+$825K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$405K |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$105K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$81.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$749K |
| 2 |
Millennium Management
New York
|
-$660K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$218K |
| 4 |
Renaissance Technologies
New York
|
-$158K |
| 5 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$157K |
IRON Hedge Fund Activity: Q3 2022 in Review
44 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Disc Medicine (IRON) for Q3 2022, worth a combined $34.3M — up 1.8% from $33.7M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of IRON and 6 opened new positions — a net loss of 6 holders — while 14 trimmed existing stakes and 8 added.
The largest buyer was Adage Capital Partners, adding an estimated $2.46M. The largest seller was Ikarian Capital, exiting entirely with an estimated $749K sold.
- 44 institutional investors held Disc Medicine (IRON) as of Q3 2022, down from 50 in Q2 2022.
- Funds reported $34.3M of Disc Medicine stock for Q3 2022, up 1.8% quarter-over-quarter.
- 6 funds opened new Disc Medicine positions in Q3 2022 and 12 closed out, a net change of -6 holders.
- The largest Disc Medicine buyer in Q3 2022 was Adage Capital Partners, an estimated $2.46M added.
- The largest Disc Medicine seller in Q3 2022 was Ikarian Capital, an estimated $749K sold.
Based on aggregated 13F filings for Q3 2022.